Fundraising Fox株式会社HIROTSUバイオサイエンス
Tokyo, JP · 1 known investors
Find your way into 株式会社HIROTSUバイオサイエンス
Sign up to see every warm intro you have to 株式会社HIROTSUバイオサイエンス
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社HIROTSUバイオサイエンス team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HIROTSUS Bioscience develops N-NOSE, a cancer screening test that uses nematodes to detect trace odor markers in urine samples, enabling early cancer detection. The company operates in medical diagnostics and contributes to public health through research and development.
Founders & leadership
広
広津崇亮
Investors · 1
Frequently asked questions
- What does 株式会社HIROTSUバイオサイエンス do?
- HIROTSUS Bioscience develops N-NOSE, a cancer screening test that uses nematodes to detect trace odor markers in urine samples, enabling early cancer detection. The company operates in medical diagnostics and contributes to public health through research and development.
- Who founded 株式会社HIROTSUバイオサイエンス?
- 株式会社HIROTSUバイオサイエンス was founded by 広津崇亮.
- Who are 株式会社HIROTSUバイオサイエンス's investors?
- 株式会社HIROTSUバイオサイエンス's investors include Iyogin Capital.
- Where is 株式会社HIROTSUバイオサイエンス headquartered?
- 株式会社HIROTSUバイオサイエンス is headquartered in Tokyo, JP.